Felisa Reyes‐Ortega

Author

Felisa Reyes‐Ortega

Monash University ORCID

Also Known As

F Reyes‐Ortega, F. Reyes-Ortega, Felisa Reyes-Ortega, Felisa Reyes‐Ortega, Reyes-Ortega F

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Monash University Universidad de Granada The University of Melbourne Instituto Maimónides de Investigación Biomédica de Córdoba University of Córdoba

About

Felisa Reyes‐Ortega is an author at Monash University specializing in engineering, medicine, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	308
2	Medicine	9	9	270
3	Biomedical Engineering	9	9	271
4	Biomolecular Engineering	2	2	62
5	Health Sciences	1	1	57

Felisa Reyes‐Ortega

Publications

926

Citations

H-Index

Page 1

	Year	Citations
Tuning gelatin-based hydrogel towards bioadhesive ocular tissue engineering applications Sina Sharifi, Mohammad Mirazul Islam, Hannah Sharifi, Bioactive Materials	2021	160
Chitosan&ndash;tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and&nbsp;antiulcerogenic activity L Servat-Medina, Álvaro González‐Gómez, Felisa Reyes‐Ortega, International Journal of Nanomedicine	2015	111
Magnetic Nanoparticles Coated with a Thermosensitive Polymer with Hyperthermia Properties Felisa Reyes‐Ortega, Á.V. Delgado, Elena K. Schneider‐Futschik, Polymers NanoparticlesMaterials ScienceMagnetic PropertiesNanomedicineNanotherapeutics	2017	94
Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies Felisa Reyes‐Ortega, Á.V. Delgado, Guillermo R. Iglesias Nanomaterials	2021	77
From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative “Superbugs” Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators Maytham Hussein, Elena K. Schneider‐Futschik, Alysha G. Elliott, Microbial Drug Resistance Antimicrobial ChemotherapyNovel Therapeutic ApproachesBacterial PathogensDrug ResistanceAntimicrobial Therapy	2016	57
Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO Elena K. Schneider‐Futschik, Felisa Reyes‐Ortega, John Wilson, Journal of Chromatography B Translational MedicineMedicineCystic Fibrosis PatientsLc–ms/ms MethodsImmunology	2016	55
Bioactive bilayered dressing for compromised epidermal tissue regeneration with sequential activity of complementary agents Felisa Reyes‐Ortega, Alberto Cifuentes, María Rosa Aguilar, Acta Biomaterialia Regenerative MedicineTissue EngineeringEngineeringCutaneous BiologyComplementary Agents	2015	46
The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites Elena K. Schneider‐Futschik, Rachel M. McQuade, Vincenzo Carbone, ERJ Open Research	2018	37
Hyperthermia-Triggered Gemcitabine Release from Polymer-Coated Magnetite Nanoparticles Guillermo R. Iglesias, Felisa Reyes‐Ortega, Blanca Luna Checa Fernández, Polymers NanoparticlesNanotherapeuticsEngineeringHyperthermia-triggered Gemcitabine ReleaseChemistry	2018	37
Multiple Reaction Monitoring Mass Spectrometry for the Drug Monitoring of Ivacaftor, Tezacaftor, and Elexacaftor Treatment Response in Cystic Fibrosis: A High-Throughput Method Felisa Reyes‐Ortega, Fiona Qiu, Elena K. Schneider‐Futschik ACS Pharmacology & Translational Science	2020	33

Page 1